——————————————————————
All that Jerry Mosemak (@jmosemak), Connie Mosemak, and Mosemak Creative(@mosemakcreative) wanted to know was what Twitter thought of their Twerk——————————————————————

——————————————————————Bob Blaskiewicz, fresh off the AstroTurf campaign with “Orac’s”orifice, seemed ready to really be headed, right in to rectify on Liz’s——————————————————————

——————————————————————Liz, do you really want this anywhere around your backside ?——————————————————————

——————————————————————Bob-B obviously confused Liz Szabo with being a “journalist“, when she is a “reporter“

Ms. Szabo, is obviously NOT a“journalist”
——————————————————————Liz Szabo(USA TODAY) – health reporter, medical reporter covering cancer, heart disease, pediatrics, public health, women’s health, kids/parenting, …
——————————————————————
The question is, how did a “reporter” like Liz Szabo, manage to get her name as the reporter“headlining”“The Skeptics™”“report,” instead of Robert Hanashiro?

Hanashiro had under his belt:
——————————————————————8/3/2011 – Urine test may help predict prostate cancer risk [4]
——————————————————————
The best Szabo could cite as support was:
——————————————————————3/19/2008 – “Prostate cancer treatments’ sexual, urinary side effects compared”[5]
——————————————————————
Exactly how didLiz Szabo“win” that “pissing contest”?

Even a monkey can report the news:

10/18/2013 – Monkeys ‘talk in turns’ [6]

If @LizSzabo wanted to do a REALarticle on “selling false hope to cancer patients”, then USA TODAY should have done an “investigation” on something like THIS:======================================8/25/2010, Wednesday[7]
——————————————————————Canadian Man Sentenced to 33 Months (2 years 9 months) in Prison for Selling Counterfeit Cancer Drugs Using the Internet

Doctor at University of Alberta in Canada published report in early 2007 summarizing results of study, which showed DCA caused regression in several cancers, including:
1. breast cancer
2. cancerous brain tumors
3. lung cancer

According to information contained in plea agreement, DCA cannot be prescribed by medical doctor in:
1. United States
or
2. Canada
since:
1. it is not approved for use in patients with cancer
2. nor is DCA available in pharmacies

“Gaber used the Internet to victimize people already suffering from the effects of cancer,”

said Dennis K. Burke, U.S. Attorney for District of Arizona

“Now he will go to prison for this bogus business and heartless fraud.”

“The FBI and the U.S. Attorney’s Office are committed to pursuing individuals who prey on those who are living with the affects of cancer,”

said Nathan Gray, Special Agent in Charge of FBI Phoenix Division

“Today’s sentencing illustrates international law enforcement partners working together to send a message not to use the Internet to perpetuate fraud, especially against those afflicted with a serious medical condition.”

Sentencing part of larger department-wide effort led by Department of Justice Task Force on Intellectual Property (IP Task Force)

Attorney General Eric Holder created IP Task Force to combat growing number of:
1. domestic
2. international
3. intellectual property crimes
protect:
1. health
2. safety
of American consumers
safeguard nation’s economic security against those who seek to profit illegally from American creativity, innovation and hard work

Criminal Division’s Office of International Affairs provided assistance in case

Case investigated by Phoenix FBI Cyber Squad
10-958 Criminal Division======================================7/30/2013 – United States to Settle Cancer Research Grant Fraud [8]
——————————————————————Northwestern University to Pay Nearly $3 Million to United States to Settle Cancer Research Grant Fraud Claims

$2.93 million – Northwestern University will pay United States to settle claims of cancer research grant fraud by former researcher and physician at university’sRobert H. Lurie Comprehensive Center for Cancer in Chicago

Agreed to settlement in federal False Claims Act lawsuit after government investigated claims made by former employee and whistleblower who will receive portion of settlement

Alledgedly allowed researcher, Dr. Charles L. Bennett, to submit false claims under research grants from National Institutes of Health

Allegations made in civil lawsuit filed under seal 2009 by Melissa Theis, (2007 and 2008) worked as purchasing coordinator in hematology and oncology at Northwestern’s Feinberg School of Medicine, will receive $498,100 in settlement proceeds

Alleged defendants submitted false claims to United States when:
1. Dr. Bennett
2. Dr. Rosen
directed and authorized spending of grant funds on goods and services that did not meet applicable NIH and government grant guidelines

Government contends has certain civil claims against Northwestern arising out of Northwestern’s improper submission of claims to NIH for grant expenditures for items that were for personal benefit of:
1. Dr. Bennett
2. family
3. friends
incurred in connection with grants as to which he was principal investigator

Northwestern, fully cooperated during investigation, did not admit liability as part of settlement

Agreement releases university and all its affiliates and employees, other than Dr. Bennett, from claims made in whistleblower lawsuit

At Dr. Bennett’s request, Northwestern allegedly improperly subcontracted with various universities for services that were paid for by NIH grants

Allegations investigated by:
1. Federal Bureau of Investigation
2. National Institutes of Health
3. U.S. Attorney’s Office
4. U.S. Department of Health and Human Services Office of Inspector General

“Allowing researchers to use federal grant money to pay for personal travel, hotels, and meals, and to hire unqualified friends and relatives as ‘consultants’ violates the public’s trust,”

said Gary S. Shapiro, United States Attorney for Northern District of Illinois

“This settlement, combined with the willingness of insiders to report fraud, should help deter such misconduct, but when it doesn’t, federal grant recipients who allow the system to be manipulated should know that we will aggressively pursue all available legal remedies,”

he added

“The mismanagement or improper expenditure of grant funds is unacceptable and will not be tolerated,”

said Lamont Pugh III, Special Agent-in-Charge of U.S. Department of Health and Human Services, Office of Inspector General – Chicago Region

“The OIG will continue to diligently investigate allegations of this nature to ensure that taxpayer dollars are being properly utilized.”

“The FBI takes allegations of fraud seriously, especially those allegations from insiders who are often in the best position to detect wrongdoing long before it would otherwise come to the attention of law enforcement.”

United States represented by:
Assistant U.S. Attorney Kurt N. Lindland

Under federal False Claims Act, defendants may be liable for triple amount of actual damages and civil penalties between $5,500 and $11,000 for each violation

Individual whistleblowers may be eligible to receive between 15 and 30 percent of amount of any recovery======================================Show EmorME the Money ! [9]
——————————————————————8/28/2013, Wednesday

$1.5 Million – Emory University False Claims Act Investigation

University Overbilled Medicare and Medicaid for Patients Enrolled in Clinical Trial Research at Emory’s Winship Cancer Institute

For further information please contact U.S. Attorney’s Public Affairs Office at USAGAN.PressEmails@usdoj.gov

Internet address for HomePage for U.S. Attorney’s Office for Northern District of Georgiahttp://www.justice.gov/usao/gan.
Emory Settlement Agreement======================================5/24/1993 – Court Testimony Of Nicholas Patronas, MD:
——————————————————————Pg. 122
——————————————————————“We have done– we have an experimental protocol at the NIH where we inject a chemotherapeutic agent through the carotid artery, the artery that goes to the brain, and we have three survivals with this technique, by providing massive amounts of chemotherapeutic drugs to the brain that harbors the tumor“

“And we destroy the tumor, but we destroy a large part of the brain as well, and the patients became severely handicapped, and a life that’s not worth living“
——————————————————————Pg. 123
——————————————————————“And so I have three cases with this particular experimental protocol which resulted in killing the tumor, but a large part of the healthy brain as well“

“So overall the protocol was abandoned and is not any more in effect because of the serious side effects that we witnessed”
——————————————————————Nicholas J. PatronasNational Institutes of Health(NIH)http://www.cc.nih.gov/drd/staff/nicholas_patronas.html
——————————————————————Sharon Hill, you’re just a footnote to this article, because all you did was “cut-and-paste”, and try to pass off David H. Gorski, M.D., Ph.D., FACS and Bob Blaskiewicz as “reliable sources”

======================================GlaxoSmithKline======================================$3 BILLION——————————————————————7/2/2012——————————————————————(4/1998 – 8/2003)
——————————————————————United StatesallegesGSKparticipated inpreparing
publishing
distributingmisleading medical journal article that misreported that clinical trial of drug demonstrated efficacy in treatment when study failed to demonstrate efficacy
——————————————————————
At same time, United Statesalleges, GSKdidn’t make available data from 2 other studies in which drug also failed to demonstrate efficacy
——————————————————————(2001 – 2007)
——————————————————————United StatesallegesGSKfailed to include certain safety data about drug in reports to FDA meant to allow FDA to determine if drug continues to be safe for approved indications and to spot drug safety trends
——————————————————————missing information included data regarding certain post-marketing studies
——————————————————————data regarding 2 studies undertaken in response to European regulators’ concerns about safety of drug
——————————————————————United StatesallegesGSKstated drug had positive cholesterol profile despite having no well-controlled studies to support that message======================================

======================================Johnson & Johnson (J&J) and subsidiaries, Janssen Pharmaceuticals Inc. and Scios Inc.
Janssen Pharmaceutica Products, L.P.======================================$2.2 BILLION +——————————————————————11/4/2013, Monday——————————————————————Johnson & Johnson (J&J) and Janssen
——————————————————————complaint allegesJ&J and Janssen were aware drug posed serious health risks, but companies downplayed these risks
——————————————————————
For example, whenJ&Jstudy of drug showed significant risk of strokes and other adverse events in patients, complaint alleges Janssencombined study data with other studies to make it appear there was lower overall risk of adverse events
——————————————————————year afterJ&Jreceived results of 2nd study confirming increased safety risk for patients taking drug, but hadn’t published data, one physician who worked on study cautionedJanssen
——————————————————————“[a]t this point, so long after [the study] has been completed … we must be concerned that this gives the strong appearance that Janssen is purposely withholding the findings.”
——————————————————————complaint allegesJanssenknew patients taking drug had increased risk, but nonetheless promoted drug as “uncompromised by safety concerns”
——————————————————————WhenJanssenreceived initial results of studies indicating drug posed same risk as other antipsychotics, complaint alleges company retained outside consultants to re-analyze study results and ultimately published articles stating drug was actually associated with lower risk
——————————————————————J&J and another of its subsidiaries, Scios Inc.
——————————————————————8/2001 – FDA approved drug to treat patients with acutely decompensated congestive heart failure who have shortness of breath at rest or with minimal activity
——————————————————————approval based on study involving hospitalized patients experiencing severe heart failure who received infusions of drug over average 36-hour period
——————————————————————complaint allegedScioshad no sound scientific evidence supporting medical necessity of outpatient infusions and misleadingly used small pilot study to encourage serial outpatient use of drug======================================

======================================Abbott Laboratories Inc.======================================$1.5 BILLION——————————————————————5/7/2012, Monday——————————————————————(2001 – 2006)
——————————————————————
company marketed drug in combination with atypical antipsychotic drugs even after its clinical trials failed to demonstrate adding drug was any more effective than atypical antipsychotic alone for that use
——————————————————————1999 – forced to discontinue clinical trial of drug due to increased incidence of adverse events, including
somnolence
dehydration
anorexiaexperienced by study participants administered drug
——————————————————————funded 2 studies of use of drugboth failed to meet main goals established for the study
——————————————————————When 2nd study failed to show statistically significant treatment difference between antipsychotic drugs used in combination with drug and antipsychotic drugs alone, waited nearly 2 years to notify sales force about study results and another 2 years to publish results======================================

======================================AstraZeneca LP / AstraZeneca Pharmaceuticals LP======================================$520 MILLION——————————————————————4/27/2010, Tuesday——————————————————————engaged doctors to conduct studies on unapproved uses of drug
——————————————————————recruited doctors to serve as authors of articles that were ghostwritten by medical literature companies and about studies doctors in question didn’t conduct
——————————————————————then usedstudies
articlesas basis for promotional messages aboutunapproved uses of drug======================================REFERENCE:======================================11/26/2013 – United States Department of Justice (DOJ) versus BIG Pharma: BIG Pharma fought the law, and the law won ?:
——————————————————————https://stanislawrajmundburzynski.wordpress.com/2013/11/26/united-states-department-of-justice-versus-big-pharma-big-pharma-fought-the-law-and-the-law-won/
======================================